Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study - Takeaways - MDSpire

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

  • By

  • Jong Hyuk Lee

  • Ho Cheol Kim

  • Kyu-Won Jung

  • Chang Min Choi

  • June 8, 2026

  • 0 min

Share

  • 1

    Non-small-cell lung cancer (NSCLC) is a leading cause of cancer-related mortality, influenced by diagnosis stage and molecular biomarkers.

  • 2

    The Korea Central Cancer Registry provides a large, multicenter dataset suitable for developing predictive models for NSCLC.

  • 3

    A deep learning model was developed to predict 5-year mortality in NSCLC using nationwide data and routine clinical features.

  • 4

    The model employed a grouped-input architecture to enhance interpretability and transparency in feature contribution assessment.

  • 5

    Data preprocessing included careful handling of missing information and stratified splitting to ensure robust model training and evaluation.

Original Source(s)

Predicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study

  • by Jong Hyuk Lee, Ho Cheol Kim, Kyu-Won Jung, Chang Min Choi

  • June 8, 2026

Related Content

Knowledge, attitudes, and practices toward chemotherapy resistance among oncologists: a multinational cross-sectional study

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial

TIFA: a signaling hub linking inflammation, innate immunity, and human disease